Empowering client, providers and members Building a trusted, transparent PBM Tab 1 2021 – Current 2015 – 2020 2010 – 2014 1998 – 2009 Helping improve care, reducing cost through integration See our...

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares how to identify fake GLP-1s

NMPI: National Medicaid Pooling Initiative We negotiate the best price available from the pharmaceutical industry on behalf of our participating clients. View resources Services we offer Our...

Nationwide effort on Oct. 25 offers opportunity to safely dispose of unused or expired medications

Notice of privacy practices Effective Date: January 2026 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE...

Zabrina Watkins Radical welcomeness “At Prime, our success is largely based on our team. Ensuring we create and maintain an environment that is positive, engaging and welcoming to all is a...

Education information Biometric information Legally protected classification characteristics We collect this information directly from you when you provide it by applying for a job, accepting a job...

publications As CAR T evolves, so does the site of care July 21, 2026 Author: Caroline Quinn, PharmD, BCOP For much of its commercial history, chimeric antigen receptor T-cell (CAR T) therapy has...

Effective Date: July 1, 2026 Introduction, scope, and purpose: Prime Therapeutics LLC and all of its operating units and subsidiaries (“Prime,” “we,” “our”) understands that the privacy of your...

publications Summer 2024 Prime Therapeutics Report June 11, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. This issue’s cover story...